Ultragenyx Pharmaceuticals To Present At The Biocentury Future Leaders In The Biotech Industry Conference
Published: Mar 21, 2014
Novato, CA, March 21, 2014 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced that Emil D. Kakkis, M.D., Ph.D., the company's Chief Executive Officer, will be presenting at the BioCentury Future Leaders in the Biotech Industry Conference on March 28, 2014 at 2:00pm ET at the Millennium Broadway Hotel & Conference Center in New York.
Help employers find you! Check out all the jobs and post your resume.